Broker suggests radical Reckitt Benckiser split

Add to My Stories Print page Add to Favourites

A broker believes that a radical restructuring of Reckitt Benckiser’s (RB) business is likely if, as he believes is probable, it succeeds in buying Pfizer’s consumer health business. Robert Waldschmidt…